These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36355980)

  • 1. Safety and Efficacy of HU-014 in the Treatment of Post-Stroke Upper Limb Spasticity: A Phase I Pilot Study.
    Lee J; Chun MH
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox
    Ye DH; Chun MH; Park YG; Paik NJ; Lee SU; Yoo SD; Kim DY
    Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ; Kwon BS; Park YG
    Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG; Paik NJ; Lee SU; Oh BM; Chun MH; Kwon BS; Bang MS
    PLoS One; 2015; 10(6):e0128633. PubMed ID: 26030192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of MT10107 in post-stroke upper limb spasticity treatment: A phase I randomized controlled trial.
    Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ
    Medicine (Baltimore); 2022 Nov; 101(44):e31367. PubMed ID: 36343044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
    Masakado Y; Abo M; Kondo K; Saeki S; Saitoh E; Dekundy A; Hanschmann A; Kaji R;
    J Neurol; 2020 Jul; 267(7):2029-2041. PubMed ID: 32219557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
    Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
    Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study.
    Lee J; Yang SN
    Toxins (Basel); 2024 Apr; 16(4):. PubMed ID: 38668622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis.
    Kaňovský P; Elovic EP; Munin MC; Hanschmann A; Pulte I; Althaus M; Hiersemenzel R; Marciniak C
    J Rehabil Med; 2021 Jan; 53(1):jrm00138. PubMed ID: 33112408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
    J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.